Analyze Diet
Journal of veterinary internal medicine2011; 25(3); 586-591; doi: 10.1111/j.1939-1676.2011.0715.x

Equine encephalomyelitis outbreak caused by a genetic lineage 2 West Nile virus in Hungary.

Abstract: The spread of lineage 2 West Nile virus (WNV) from sub-Saharan regions to Europe and the unpredictable change in pathogenicity indicate a potential public and veterinary health threat and requires scientific awareness. Objective: To describe the results of clinical and virological investigations of the 1st outbreak of a genetic lineage 2 WNV encephalomyelitis in horses. Methods: Seventeen horses with neurologic signs. Methods: Information regarding signalment, clinical signs, and outcome was obtained for each animal. Serology was performed in 15 cases, clinicopathological examination in 7 cases, and cerebrospinal fluid was collected from 2 horses. Histopathology was carried out in 4 horses, 2 of which were assessed for the presence of WNV in their nervous system. Results: WNV neutralizing antibody titers were between 10 and 270 (median, 90) and the results of other serological assays were in agreement with those of the plaque reduction neutralization test. Common signs included ataxia, weakness, asymmetric gait, muscle tremors, hypersensitivity, cranial nerve deficits, and recumbency. Twelve animals survived. Amplicons derived from the infection-positive specimens allowed molecular characterization of the viral strain. Conclusions: From our results, we conclude that this outbreak was caused by a lineage 2 WNV strain, even though such strains often are considered nonpathogenic. Neurological signs and survival rates were similar to those reported for lineage 1 virus infections. The disease occurrence was not geographically limited as had been the typical case during European outbreaks; this report describes a substantial northwestern spread of the pathogen.
Publication Date: 2011-04-01 PubMed ID: 21457323DOI: 10.1111/j.1939-1676.2011.0715.xGoogle Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The study outlines an outbreak of Equine encephalomyelitis caused by a lineage 2 West Nile virus (WNV) amongst horses in Hungary. Interestingly, the lineage 2 WNV strain, usually considered nonpathogenic, exhibited similar neurological symptoms and survival rates as the pathogenic lineage 1 virus infections in previous outbreaks.

Objective and Methodology

The objective of the research was to understand the clinical and virological aspects of the first outbreak of lineage 2 West Nile virus encephalomyelitis in horses. The study involved analysis on 17 horses showing neurological signs of the disease.

  • Data on each animal’s signalment, clinical signs, and outcome was collected.
  • Serology, the study of blood serum, was carried out on 15 horses.
  • A clinicopathological examination was conducted on 7 horses.
  • Cerebrospinal fluid was collected from 2 horses for analysis.
  • 4 horses underwent a histopathology examination, with 2 of these horses studied for presence of WNV in their nervous system.

Results

The findings showed that WNV neutralizing antibody titers in horses ranged between 10 and 270, with a median of 90. The symptoms most observed included ataxia, weakness, asymmetric gait, muscle tremors, hypersensitivity, cranial nerve deficits, and recumbency. Of the 17 horses affected, 12 survived.

Additionally, the viral strain was molecularly characterized through amplicons derived from the infection-positive specimens. This allowed the researchers to confirm that the virus, lineage 2 WNV, was indeed involved in the outbreak.

Conclusions

The findings concluded that the outbreak was caused by a lineage 2 WNV strain. This is noteworthy as such strains are typically considered nonpathogenic, yet the neurological signs and survival rates observed were on par with those reported for lineage 1 infection.

The research also noted that this outbreak indicated a geographic spread of the pathogen which was not typical in European outbreaks. This observed shift could be significant for future tracking and prevention strategies against such pathogens.

Cite This Article

APA
Kutasi O, Bakonyi T, Lecollinet S, Biksi I, Ferenczi E, Bahuon C, Sardi S, Zientara S, Szenci O. (2011). Equine encephalomyelitis outbreak caused by a genetic lineage 2 West Nile virus in Hungary. J Vet Intern Med, 25(3), 586-591. https://doi.org/10.1111/j.1939-1676.2011.0715.x

Publication

ISSN: 1939-1676
NlmUniqueID: 8708660
Country: United States
Language: English
Volume: 25
Issue: 3
Pages: 586-591

Researcher Affiliations

Kutasi, O
  • Large Animal Clinic, Faculty of Veterinary Science, Szent Istvan University, Ullo, Hungary. kutasi.orsolya@aotk.szie.hu
Bakonyi, T
    Lecollinet, S
      Biksi, I
        Ferenczi, E
          Bahuon, C
            Sardi, S
              Zientara, S
                Szenci, O

                  MeSH Terms

                  • Animals
                  • Antibodies, Viral / blood
                  • Disease Outbreaks / veterinary
                  • Female
                  • Horse Diseases / blood
                  • Horse Diseases / epidemiology
                  • Horse Diseases / virology
                  • Horses
                  • Hungary / epidemiology
                  • Immunoglobulin M / blood
                  • Male
                  • Phylogeny
                  • West Nile Fever / blood
                  • West Nile Fever / epidemiology
                  • West Nile Fever / veterinary
                  • West Nile Fever / virology
                  • West Nile virus / genetics
                  • West Nile virus / immunology
                  • West Nile virus / isolation & purification

                  Citations

                  This article has been cited 26 times.
                  1. Schwarz ER, Long MT. Comparison of West Nile Virus Disease in Humans and Horses: Exploiting Similarities for Enhancing Syndromic Surveillance.. Viruses 2023 May 24;15(6).
                    doi: 10.3390/v15061230pubmed: 37376530google scholar: lookup
                  2. Fehér OE, Fehérvári P, Tolnai CH, Forgách P, Malik P, Jerzsele Á, Wagenhoffer Z, Szenci O, Korbacska-Kutasi O. Epidemiology and Clinical Manifestation of West Nile Virus Infections of Equines in Hungary, 2007-2020.. Viruses 2022 Nov 18;14(11).
                    doi: 10.3390/v14112551pubmed: 36423160google scholar: lookup
                  3. Cavalleri JV, Korbacska-Kutasi O, Leblond A, Paillot R, Pusterla N, Steinmann E, Tomlinson J. European College of Equine Internal Medicine consensus statement on equine flaviviridae infections in Europe.. J Vet Intern Med 2022 Nov;36(6):1858-1871.
                    doi: 10.1111/jvim.16581pubmed: 36367340google scholar: lookup
                  4. Farooq Z, Rocklöv J, Wallin J, Abiri N, Sewe MO, Sjödin H, Semenza JC. Artificial intelligence to predict West Nile virus outbreaks with eco-climatic drivers.. Lancet Reg Health Eur 2022 Jun;17:100370.
                    doi: 10.1016/j.lanepe.2022.100370pubmed: 35373173google scholar: lookup
                  5. Bergmann F, Trachsel DS, Stoeckle SD, Bernis Sierra J, Lübke S, Groschup MH, Gehlen H, Ziegler U. Seroepidemiological Survey of West Nile Virus Infections in Horses from Berlin/Brandenburg and North Rhine-Westphalia, Germany.. Viruses 2022 Jan 25;14(2).
                    doi: 10.3390/v14020243pubmed: 35215837google scholar: lookup
                  6. de Heus P, Kolodziejek J, Hubálek Z, Dimmel K, Racher V, Nowotny N, Cavalleri JV. West Nile Virus and Tick-Borne Encephalitis Virus Are Endemic in Equids in Eastern Austria.. Viruses 2021 Sep 19;13(9).
                    doi: 10.3390/v13091873pubmed: 34578454google scholar: lookup
                  7. Constant O, Bollore K, Clé M, Barthelemy J, Foulongne V, Chenet B, Gomis D, Virolle L, Gutierrez S, Desmetz C, Moares RA, Beck C, Lecollinet S, Salinas S, Simonin Y. Evidence of Exposure to USUV and WNV in Zoo Animals in France.. Pathogens 2020 Nov 30;9(12).
                    doi: 10.3390/pathogens9121005pubmed: 33266071google scholar: lookup
                  8. Habarugira G, Suen WW, Hobson-Peters J, Hall RA, Bielefeldt-Ohmann H. West Nile Virus: An Update on Pathobiology, Epidemiology, Diagnostics, Control and "One Health" Implications.. Pathogens 2020 Jul 19;9(7).
                    doi: 10.3390/pathogens9070589pubmed: 32707644google scholar: lookup
                  9. de Heus P, Kolodziejek J, Camp JV, Dimmel K, Bagó Z, Hubálek Z, van den Hoven R, Cavalleri JV, Nowotny N. Emergence of West Nile virus lineage 2 in Europe: Characteristics of the first seven cases of West Nile neuroinvasive disease in horses in Austria.. Transbound Emerg Dis 2020 May;67(3):1189-1197.
                    doi: 10.1111/tbed.13452pubmed: 31840920google scholar: lookup
                  10. Nagy A, Mezei E, Nagy O, Bakonyi T, Csonka N, Kaposi M, Koroknai A, Szomor K, Rigó Z, Molnár Z, Dánielisz Á, Takács M. Extraordinary increase in West Nile virus cases and first confirmed human Usutu virus infection in Hungary, 2018.. Euro Surveill 2019 Jul;24(28).
                  11. Faverjon C, Vial F, Andersson MG, Lecollinet S, Leblond A. Early detection of West Nile virus in France: quantitative assessment of syndromic surveillance system using nervous signs in horses.. Epidemiol Infect 2017 Apr;145(5):1044-1057.
                    doi: 10.1017/S0950268816002946pubmed: 27938434google scholar: lookup
                  12. Faverjon C, Andersson MG, Decors A, Tapprest J, Tritz P, Sandoz A, Kutasi O, Sala C, Leblond A. Evaluation of a Multivariate Syndromic Surveillance System for West Nile Virus.. Vector Borne Zoonotic Dis 2016 Jun;16(6):382-90.
                    doi: 10.1089/vbz.2015.1883pubmed: 27159212google scholar: lookup
                  13. Dridi M, Van Den Berg T, Lecollinet S, Lambrecht B. Evaluation of the pathogenicity of West Nile virus (WNV) lineage 2 strains in a SPF chicken model of infection: NS3-249Pro mutation is neither sufficient nor necessary for conferring virulence.. Vet Res 2015 Oct 30;46:130.
                    doi: 10.1186/s13567-015-0257-1pubmed: 26518144google scholar: lookup
                  14. Chaintoutis SC, Diakakis N, Papanastassopoulou M, Banos G, Dovas CI. Evaluation of Cross-Protection of a Lineage 1 West Nile Virus Inactivated Vaccine against Natural Infections from a Virulent Lineage 2 Strain in Horses, under Field Conditions.. Clin Vaccine Immunol 2015 Sep;22(9):1040-9.
                    doi: 10.1128/CVI.00302-15pubmed: 26178384google scholar: lookup
                  15. Sule WF, Oluwayelu DO, Adedokun RA, Rufai N, McCracken F, Mansfield KL, Johnson N. High seroprevelance of West Nile virus antibodies observed in horses from southwestern Nigeria.. Vector Borne Zoonotic Dis 2015 Mar;15(3):218-20.
                    doi: 10.1089/vbz.2014.1706pubmed: 25793479google scholar: lookup
                  16. Prow NA, Setoh YX, Biron RM, Sester DP, Kim KS, Hobson-Peters J, Hall RA, Bielefeldt-Ohmann H. The West Nile virus-like flavivirus Koutango is highly virulent in mice due to delayed viral clearance and the induction of a poor neutralizing antibody response.. J Virol 2014 Sep 1;88(17):9947-62.
                    doi: 10.1128/JVI.01304-14pubmed: 24942584google scholar: lookup
                  17. Hoover LI, Fredericksen BL. IFN-dependent and -independent reduction in West Nile virus infectivity in human dermal fibroblasts.. Viruses 2014 Mar 24;6(3):1424-41.
                    doi: 10.3390/v6031424pubmed: 24662674google scholar: lookup
                  18. Donadieu E, Lowenski S, Servely JL, Laloy E, Lilin T, Nowotny N, Richardson J, Zientara S, Lecollinet S, Coulpier M. Comparison of the neuropathology induced by two West Nile virus strains.. PLoS One 2013;8(12):e84473.
                    doi: 10.1371/journal.pone.0084473pubmed: 24367664google scholar: lookup
                  19. Marka A, Diamantidis A, Papa A, Valiakos G, Chaintoutis SC, Doukas D, Tserkezou P, Giannakopoulos A, Papaspyropoulos K, Patsoula E, Badieritakis E, Baka A, Tseroni M, Pervanidou D, Papadopoulos NT, Koliopoulos G, Tontis D, Dovas CI, Billinis C, Tsakris A, Kremastinou J, Hadjichristodoulou C, Vakalis N, Vassalou E, Zarzani S, Zounos A, Komata K, Balatsos G, Beleri S, Mpimpa A, Papavasilopoulos V, Rodis I, Spanakos G, Tegos N, Spyrou V, Dalabiras Z, Birtsas P, Athanasiou L, Papanastassopoulou M, Ioannou C, Athanasiou C, Gerofotis C, Papadopoulou E, Testa T, Tsakalidou O, Rachiotis G, Bitsolas N, Mamouris Z, Moutou K, Sarafidou T, Stamatis K, Sarri K, Tsiodras S, Georgakopoulou T, Detsis M, Mavrouli M, Stavropoulou A, Politi L, Mageira G, Christopoulou V, Diamantopoulou G, Spanakis N, Vrioni G, Piperaki ET, Mitsopoulou K, Kioulos I, Michaelakis A, Stathis I, Tselentis I, Psaroulaki A, Keramarou M, Chochlakis D, Photis Y, Konstantinou M, Manetos P, Tsobanoglou S, Mourelatos S, Antalis V, Pergantas P, Eleftheriou G. West Nile virus state of the art report of MALWEST Project.. Int J Environ Res Public Health 2013 Dec 2;10(12):6534-610.
                    doi: 10.3390/ijerph10126534pubmed: 24317379google scholar: lookup
                  20. Prow NA. The changing epidemiology of Kunjin virus in Australia.. Int J Environ Res Public Health 2013 Nov 25;10(12):6255-72.
                    doi: 10.3390/ijerph10126255pubmed: 24287851google scholar: lookup
                  21. Donadieu E, Bahuon C, Lowenski S, Zientara S, Coulpier M, Lecollinet S. Differential virulence and pathogenesis of West Nile viruses.. Viruses 2013 Nov 22;5(11):2856-80.
                    doi: 10.3390/v5112856pubmed: 24284878google scholar: lookup
                  22. Pauli G, Bauerfeind U, Blümel J, Burger R, Drosten C, Gröner A, Gürtler L, Heiden M, Hildebrandt M, Jansen B, Montag-Lessing T, Offergeld R, Seitz R, Schlenkrich U, Schottstedt V, Strobel J, Willkommen H. West nile virus.. Transfus Med Hemother 2013 Aug;40(4):265-84.
                    doi: 10.1159/000353698pubmed: 24179475google scholar: lookup
                  23. Angenvoort J, Brault AC, Bowen RA, Groschup MH. West Nile viral infection of equids.. Vet Microbiol 2013 Nov 29;167(1-2):168-80.
                    doi: 10.1016/j.vetmic.2013.08.013pubmed: 24035480google scholar: lookup
                  24. Hubálek Z, Ludvíková E, Jahn P, Treml F, Rudolf I, Svobodová P, Šikutová S, Betášová L, Bíreš J, Mojžíš M, Tinák M, Boldižár M, Citsoňová G, Staššíková Z. West Nile Virus equine serosurvey in the Czech and Slovak republics.. Vector Borne Zoonotic Dis 2013 Oct;13(10):733-8.
                    doi: 10.1089/vbz.2012.1159pubmed: 23919605google scholar: lookup
                  25. Clark DC, Brault AC, Hunsperger E. The contribution of rodent models to the pathological assessment of flaviviral infections of the central nervous system.. Arch Virol 2012 Aug;157(8):1423-40.
                    doi: 10.1007/s00705-012-1337-4pubmed: 22592957google scholar: lookup
                  26. Pesko KN, Ebel GD. West Nile virus population genetics and evolution.. Infect Genet Evol 2012 Mar;12(2):181-90.
                    doi: 10.1016/j.meegid.2011.11.014pubmed: 22226703google scholar: lookup